(RightWing.org) – COVID-19 has wreaked havoc on the world, and especially in the US for most of 2020. The number of cases continues to increase daily, with no obvious cure in sight. Several major agencies including the FDA, CDC and NIH, among others, have partnered together on Operation Warp Speed to help develop a vaccine by the end of 2020. In the meantime, though, a new treatment may show promise for those hospitalized with the deadly virus.
On Sunday, August 23, the FDA gave emergency use authorization (EUA) for the use of convalescent plasma.
— IFLScience (@IFLScience) August 26, 2020
President Trump made the announcement, calling the action “historic” and “a breakthrough.” He’s right. While the authorization doesn’t equate to a full FDA approval, it certainly paves the way for more patients with COVID-19 to receive the treatment.
Convalescent plasma is collected from those who’ve recovered from the novel coronavirus. Antibodies contained within the plasma help boost the immune system in its fight against the disease and improve patient recovery time. Those who have recovered are urged to donate in the hope of saving others.
There’s still so much unknown about this virus. Convalescent plasma joins remdesivir as a potential treatment. If it helps boost recovery time and ease the symptoms, it’s definitely worth looking into.
Copyright 2020, RightWing.org